As there is a growing interest in gd-IgA1 in IgAVN, the ability to detect, quantify, and extract IgA from a non-invasive biofluid to investigate its relationship with nephritis and its precise glycosylation status is attractive as it may permit earlier stratification of children at high risk of kidney failure. This evidence concerns the gene CD79A and nephritis.